312 Risk factors for acne development in the first two years of initiating masculinizing testosterone therapy among transgender men

Acne is known to correlate with masculinizing testosterone (T) therapy use in female-to-male transgender men. However, the timing of acne onset and acne risk factors in this population have not been well-studied. In this retrospective study, we explored the combined effects of T therapy and biological factors on acne development in a population of transgender men that have initiated and maintained therapy for at least two years. We identified 55 transgender men aged ≥18 who received care between January 1, 2008 - December 31, 2017 at Boston Medical Center, MA.
Source: Journal of Investigative Dermatology - Category: Dermatology Authors: Tags: Clinical Research: Epidemiology of Skin Diseases Source Type: research